nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anifrolumab in lupus: the promise and the caution
|
Jain, Siddharth |
|
|
2 |
8 |
p. e461-e462 |
artikel |
2 |
Anifrolumab in lupus: the promise and the caution – Author's reply
|
Furie, Richard |
|
|
2 |
8 |
p. e462 |
artikel |
3 |
Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?
|
Yeoh, Su-Ann |
|
|
2 |
8 |
p. e454-e456 |
artikel |
4 |
Canakinumab in a subgroup of patients with COVID-19
|
Ucciferri, Claudio |
|
|
2 |
8 |
p. e457-ee458 |
artikel |
5 |
Can tocilizumab calm the cytokine storm of COVID-19?
|
Schulert, Grant S |
|
|
2 |
8 |
p. e449-e451 |
artikel |
6 |
COVID-19 and systemic lupus erythematosus: a case series
|
Gartshteyn, Yevgeniya |
|
|
2 |
8 |
p. e452-e454 |
artikel |
7 |
Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach
|
Robinson, George A |
|
|
2 |
8 |
p. e485-e496 |
artikel |
8 |
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
|
De Luca, Giacomo |
|
|
2 |
8 |
p. e465-e473 |
artikel |
9 |
GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
|
Favalli, Ennio Giulio |
|
|
2 |
8 |
p. e448-e449 |
artikel |
10 |
Lessons for rituximab therapy in patients with rheumatoid arthritis
|
Garcia-Montoya, Leticia |
|
|
2 |
8 |
p. e497-e509 |
artikel |
11 |
Making a big impact with small datasets using machine-learning approaches
|
Choi, May Y |
|
|
2 |
8 |
p. e451-e452 |
artikel |
12 |
Opioid use in rheumatic diseases: preventing another pandemic
|
The Lancet Rheumatology, |
|
|
2 |
8 |
p. e447 |
artikel |
13 |
Pulmonary intravascular coagulopathy in COVID-19 pneumonia
|
Reines, Brandon P |
|
|
2 |
8 |
p. e458-e459 |
artikel |
14 |
Pulmonary intravascular coagulopathy in COVID-19 pneumonia
|
Brondani, Giovanni |
|
|
2 |
8 |
p. e458 |
artikel |
15 |
Pulmonary intravascular coagulopathy in COVID-19 pneumonia
|
Cárdenas Suri, Hisyovi |
|
|
2 |
8 |
p. e459-e460 |
artikel |
16 |
Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors' reply
|
McGonagle, Dennis |
|
|
2 |
8 |
p. e460-e461 |
artikel |
17 |
Research in Brief
|
Thorley, Jennifer |
|
|
2 |
8 |
p. e463 |
artikel |
18 |
Seza Ozen
|
Burki, Talha Khan |
|
|
2 |
8 |
p. e464 |
artikel |
19 |
Takayasu arteritis with pyoderma gangrenosum and superficial thrombophlebitis
|
Acharya, Nupoor |
|
|
2 |
8 |
p. e510 |
artikel |
20 |
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|
Guaraldi, Giovanni |
|
|
2 |
8 |
p. e474-e484 |
artikel |